We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPT
3976
DELISTED
RAPT Therapeutics
RAPT
$297K ﹤0.01%
1,171
-136
-10% -$25.4K
NS
3977
DELISTED
NuStar Energy L.P.
NS
$297K ﹤0.01%
16,890
-1,996
-11% -$37K
EWG icon
3978
iShares MSCI Germany ETF
EWG
$1.62B
$295K ﹤0.01%
+8,502
New +$299K
FCBC icon
3979
First Community Bankshares
FCBC
$918M
$295K ﹤0.01%
9,877
-1,917
-16% -$57.9K
LPG icon
3980
Dorian LPG
LPG
$1.88B
$295K ﹤0.01%
20,625
+3,639
+21% +$50.9K
VPG icon
3981
Vishay Precision Group
VPG
$1.35B
$295K ﹤0.01%
8,602
+490
+6% +$16.3K
TZA icon
3982
Direxion Daily Small Cap Bear 3x ETF
TZA
$209M
$294K ﹤0.01%
+1,027
New +$323K
PVLA
3983
Palvella Therapeutics
PVLA
$2.16B
$294K ﹤0.01%
959
-59
-6% -$12.9K
MVLA
3984
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$294K ﹤0.01%
+30,000
New +$295K
BFX
3985
DELISTED
BowFlex Inc.
BFX
$293K ﹤0.01%
17,215
-4,467
-21% -$75.3K
CRK icon
3986
Comstock Resources
CRK
$3.87B
$292K ﹤0.01%
+44,961
New +$259K
NGM
3987
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$292K ﹤0.01%
+14,813
New +$347K
HGEN
3988
DELISTED
HUMANIGEN, INC.
HGEN
$292K ﹤0.01%
16,810
+4,047
+32% +$73.8K
BFC icon
3989
Bank First Corp
BFC
$1.73B
$289K ﹤0.01%
4,148
-203
-5% -$14.5K
CTMX icon
3990
CytomX Therapeutics
CTMX
$721M
$289K ﹤0.01%
45,723
+3,718
+9% +$29K
THFF icon
3991
First Financial Corp
THFF
$988M
$289K ﹤0.01%
7,073
-1,634
-19% -$72.5K
AMTI
3992
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$289K ﹤0.01%
6,314
-1,458
-19% -$68.9K
APD icon
3993
CALL
Air Products & Chemicals
APD
$65.7B
$288K ﹤0.01%
1,000
-1,100
-52% -$323K
BSM icon
3994
Black Stone Minerals
BSM
$3.15B
$288K ﹤0.01%
27,312
-2,019
-7% -$20.4K
CNYA icon
3995
iShares MSCI China A ETF
CNYA
$202M
$288K ﹤0.01%
6,500
NRK icon
3996
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$900M
$283K ﹤0.01%
19,973
TSHA icon
3997
Taysha Gene Therapies
TSHA
$1.76B
$283K ﹤0.01%
+13,389
New +$309K
URG
3998
Ur-Energy
URG
$513M
$283K ﹤0.01%
202,445
+2,445
+1% +$3.34K
IBCP icon
3999
Independent Bank Corp
IBCP
$796M
$282K ﹤0.01%
13,023
+955
+8% +$22K
TLS icon
4000
Telos
TLS
$364M
$281K ﹤0.01%
+8,249
New +$278K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.